SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies

Introduction Metastatic castration-resistant prostate cancer (CRPC) remains a clinical challenge despite antitumoral therapies such as taxane chemotherapeutics, enzalutamide, and abiraterone acetate. Clinical studies have highlighted the benefits of these therapies on overall and progression-free su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Snaterse, Gido, van Dessel, Lisanne, Taylor, Angela, Visser, Jenny, Arlt, Wiebke, Lolkema, Martijn, Hofland, Johannes
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Steroid Hormones and Receptors
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551668/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars